65 i b, drugs, pharmaceuticals, & hematology related products, FSS contract award

Active Awarded Last action

Contract number
36F79723D0180
Awardee
Awarding agency
Task orders
0

Award facts

Last date to order 63% complete
IDV ceiling
$17,578,191.00
Award type
Multiple award
Who can order
All agencies
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Fixed Price with Economic Price Adjustment

Award details come from SAM.gov/FPDS.

About this IDV

GSA issued a Federal Supply Schedule contract to Tris Pharma Inc. under the Pharmaceuticals and Drugs schedule (FSS-61-IB) on September 1, 2023, with a contract ceiling of $17.578 million and final completion date of August 31, 2028.

The contractor holds approval under Schedule 65 I B for drugs, pharmaceuticals, and hematology-related products. The award includes a product addition covering three National Drug Codes under initial and pro-rated pricing terms. The Veterans Integrated Service Network 12 is the funding federal agency, though as a Federal Supply Schedule vehicle, this contract serves as a multi-agency catalog from which federal agencies place orders against the contractor's price list rather than conducting individual competitions. Place of performance and specific ordering activity under this schedule contract are not detailed in the available source material.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00015 · 42-2A | product addition | 3 ndcs: NPS - initial/pro-rated - DS $0
Supplemental Agreement for work within scope P00014 · Life cycle change | initial to independent $0
Supplemental Agreement for work within scope P00013 · Administrative changes | product description change - 5 ndcs $0
Other Administrative Action P00012 · EV - mass MOD 0016 incorporation $0
Supplemental Agreement for work within scope P00011 · 42-2A | product addition (dual price) | 1 NDC (24478-0102-02) $0
Supplemental Agreement for work within scope P00010 · 2026 public law pricing updates $0
Supplemental Agreement for work within scope P00008 · Product deletion | 1 NDC (24478-0148-04) of onyda $0
Other Administrative Action P00009 · Update POC for vendor contract administrator $0
Supplemental Agreement for work within scope P00006 · Permanent price reduction (1 NDC-24478-0148-03) $0
Other Administrative Action P00005 · Incorporate updated SAF & update address and pocs $0
Supplemental Agreement for work within scope P00004 · Product addition (onyda XR - ndcs 24478-0148-03 & 04) $0
Supplemental Agreement for work within scope P00003 · 2025 public law $0
Other Administrative Action P00002 · Add sales POC. $0
Supplemental Agreement for work within scope P00001 · PL updates $0
Original award $0
Show all 15

Quick answers

Who was awarded contract 36F79723D0180?

36F79723D0180 was awarded to Tris Pharma Inc. by Veterans Integrated Service Network 12 (Veterans Health Administration) on September 1, 2023.

How much is contract 36F79723D0180 worth?

36F79723D0180's own ceiling is $17,578,191.

Who can order from contract 36F79723D0180?

36F79723D0180 is a multiple award federal supply schedule. All agencies can place orders on it.

Is contract 36F79723D0180 part of a contract vehicle?

Yes. 36F79723D0180 is part of Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36F79723D0180 competed?

The extent of competition for 36F79723D0180 was full and open competition.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV